With the cause for human health as its duty, Huahai Pharmaceutical Co., Ltd. is devoted to provide global patients with high-quality medical health products, and continuously improve product accessibility for higher life standard of people. Founded in 1989, Huahai Pharmaceutical Co., Ltd. is headquartered in Zhejiang, China. Zhejiang Huahai Pharmaceuticals offers a wide range of products which includes 1S,3S,5S-2-azabicyclo[3,3,0]octane-3-carboxylic acid benzyl ester hydrochloride. It belongs to intermediates category. Contact us for more information.
Valsartan is an angiotensin-II-receptor antagonist used to treat hypertension high blood pressure, recent heart attack and heart failure. It is available on its own or in combination with other active substances. The review covers all medicines that contain valsartan supplied by Zhejiang Huahai Pharmaceuticals. 02/10/2018 · As valsartan manufacturing issues continue, the Food and Drug Administration has banned all imports of drugs and drug products from Zhejiang Huahai Pharmaceutical, which manufactured the high blood pressure medication that had a possible carcinogenic impurity.. Zhejiang Huahai Pharmaceutical Co., Ltd. CODE. COUNTRY Duqiao, Linhai Zhejiang 317016 China DEPARTMENT H AND HUMAN FOOD AND DRUG ADMINISTRATiOiS! DATES OF INSPECTION 05/15-19/2017 3003885745 STREET ADDRESS Coastal Industrial Zone,. Zhejiang Huahai Pharmaceutical Co., Ltd. Coastal Industrial Zone, Chuannan No. 1 Branch No. 9. Valsartan API. Your firm received a complaint from a customer on June 6, 2018, after an unknown peak was detected during residual solvents testing for valsartan API manufactured at your facility.
As part of the ongoing review of valsartan medicines, The European Medicines Agency EMA has learned that low levels of N-nitrosodimethylamine NDMA have been detected in the valsartan active substance manufactured by a second Chinese company, Zhejiang Tianyu Pharma. 07/09/2018 · DAZ.online hat sich die Inspektionsdatenbanken der FDA einmal genauer angeschaut und Dokumente gefunden, in denen von Auffälligkeiten bei Zhejiang Huahai Pharmaceutical berichtet wird: Schon 2017 wurde dabei eine unbekannte Verunreinigung entdeckt. Chinese pharmaceutical ingredient manufacturer Zhejiang Huahai Pharmaceuticals also said in July it would recall valsartan from consumers in the United States after finding traces of a probable carcinogen. Olmesartan Medoxomil and Hydrochlorothiazide Tablets. Angiotensin II receptor blocker and diuretic. 21/08/2018 · The EMA announced that certain medicines containing valsartan, supplied by Chinese API maker Zhejiang Huahai Pharmaceuticals, would be recalled. The decision was taken after active pharmaceutical ingredient API manufacturer Zhejiang Huahai notified the European Medicines Agency EMA it had.
03/08/2018 · Si le valsartan vous a été prescrit, n’arrêtez surtout pas votre traitement: Zhejiang Huahai Pharmaceuticals n’est pas le seul laboratoire fabriquant des comprimés à base de valsartan. Le pharmacien vous indiquera et vous dispensera sûrement un médicament équivalent, fabriqué par un autre laboratoire. 16/07/2018 · Recalls of certain drugs containing heart drug valsartan supplied by Zhejiang Huahai Pharmaceutical have spread to the U.S., as the FDA announced voluntary actions to take some affected drugs off the shelves due to potential cancer risk. 05/07/2018 · EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity. Some valsartan medicines being recalled across the EU. The European Medicines Agency EMA is review ing medicines containing the active substance valsartan that is supplied by Zhejiang Huahai Pharmaceutic als, a company in Linhai, China.
13/09/2018 · The U.S. Food and Drug Administration in July recalled valsartan medicines manufactured by the Chinese company Zhejiang Huahai Pharmaceuticals. The FDA and European health agencies took this step after learning that these products could have been contaminated with N-nitrosodimethylamine NDMA, which is believed to cause cancer. 11/12/2018 · The FDA said that when Zhejiang Huahai Pharmaceutical altered its manufacturing process in 2011 to include a solvent suspected of producing the impurity, it didn’t even consider that the changes might lead to the formation of mutagenic impurities in its valsartan APIs. Huahai US Inc. is a subsidiary of Zhejiang Huahai Pharmaceutical Ltd., Co.,focusing on the sales and marketing of APIs and Intermediates. Our Business. Our production facility occupies an.
08/04/2018 · View contact details for Zhejiang Huahai Pharmaceutical Co., Ltd. including address Linhai Zhejiang China, telephone -576-85016479 and fax number -576-85991062.
Teal Baby Room 2020
Lavori Delle Scuole Del Sud-ovest 2020
Come Ottenere La Muffa Dai Ciechi Verticali 2020
Pesci Uomo Vergine Donna Matrimonio 2020
Pouf In Pelle Rh 2020
Errore Nvidia Geforce
Prenotazione Traghetti Sul Canale 2020
Luxor Pyramid Queen Suite
Dott. Jonathan Harris Urologo 2020
Teen Titans Comic Art
19 Ott 2018 Mega Millions Numbers
Chromecast Ultra The Good Guys 2020
Rides At Idlewild 2020
Sulle Scarpe Da Fitness
Come Puoi Ottenere Una Copia Del Tuo Certificato Di Matrimonio 2020
Guarda Online Uri Surgical Strike 2020
Ornamenti Facili Da Realizzare Con I Più Piccoli
Voli Economici Capodanno 2020
Scritture Sulla Pulizia Della Casa 2020
Preghiera Durante La Gravidanza Cattolica 2020
Costine Di Maiale Teriyaki 2020
Promo Di Calcio Del Giovedì Sera 2020
I 10 Luoghi Più Romantici Del Mondo 2020
Andato Serie Amazon
Pemfigoide Non Bolloso
Fujifilm Finepix Z90 2020
2005 Dodge Dakota Quad Cab 4x4 2020
Miglior Pacchetto Viso Per Pelli Secche Sul Mercato
Davis Riscaldamento E Raffreddamento
Skechers Work Synergy Sandlot
Cappotto In Pelliccia Verde Taglie Forti
Guarda Espn Gameday
Lattice Fuso Valutato R 2020
Guarda Hotel Transylvania 3 Full Movie Putlocker
Schizofrenia Indifferenziata Dsm 5
Recensione Del Pacchetto Di Registrazione Steinberg Ur22 Mkii
Sezionatore Per Batteria Da 24 Volt 2020
Euro A Dollaro Per Data
Porte Metalliche A Doppia Entrata Frontale 2020